James M Bjork, PhD
Virginia Commonwealth University · Hunter Holmes McGuire VA Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name James M Bjork, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:09 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05886582 · Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use DisorderVirginia Commonwealth University · completed · Substance-Related Disorders · principal investigator
- N/ANCT03662529 · Neurobehavioral Measurement of Substance Users in Outpatient Treatment SettingHunter Holmes Mcguire Veteran Affairs Medical Center · completed · Cocaine Dependence, Cocaine Use Disorder, Opiate Dependence · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use DisorderU01DA057846 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI James M Bjork · fiscal years 2022Named on NCT05886582
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.